General MedicationsOPHTHALMICGeneric

EPINASTINE HYDROCHLORIDE

Standard Dose

0.05%

Max Dose

Refer to approved labeling

Primary Use

Marketing status: None (Tentative Approval)

Summary

Approval overview EPINASTINE HYDROCHLORIDE is listed in Drugs@FDA under application 090950 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient EPINASTINE HYDROCHLORIDE Form and strength SOLUTION; OPHTHALMIC - 0.05% Sponsor SANDOZ Submission history Latest submission status date: 2011-01-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview EPINASTINE HYDROCHLORIDE is listed in Drugs@FDA under application 090950 (ANDA). Marketing status: None (Tentative Approval) Active ingredient EPINASTINE HYDROCHLORIDE Form and strength SOLUTION; OPHTHALMIC - 0.05% Sponsor SANDOZ Submission history Latest submission status date: 2011-01-27 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: None (Tentative Approval)

Interaction Notes

No interaction notes stored yet.